Trump's tariffs could hit the Hungarian pharmaceutical company too
Drugs maker expects significant growth, especially in the women's healthcare and biotech segments
Portfolio expanding
Interview with Gábor Orbán
FDA accepts license application for review
Third-quarter flash report came in
Analyst consensus available
Gynaecological product gets green light, milestone payment coming
Capacities have been expanded
Vrylar, jointly developed with US partner AbbVie, is the subject of the positive news
The pharmaceutical manufacturer did not disappoint
Analysts surveyed
Higher TP with 'Overweight' recommendation
Richter will become 100% owner of the two companies for €112 million
Erik Bogsch replaced by E. Szilveszter Vizi
From Erste
Just to be clear about the impacts
Signs Head of Terms contract with Mithra
Management addresses Q3 earnings and more
Results largely exceed analyst expectations, though